• Discounts and special offers
  • Subscriber-only articles and interviews
  • Breaking news and trending topics

Already a subscriber?

By signing up, you accept Moneywise's Terms of Use, Subscription Agreement, and Privacy Policy.

Not interested ?

Top Stories
Mehmet Oz participates in a discussion during the Conservative Political Action Conference (CPAC) at the Gaylord Texan Resort and Conference Center on March 26, 2026 Brandon Bell/Getty Images

Dr. Oz issues stunning revelation: US officials ‘took out’ 221 hospices in just 10 weeks — all of them in LA. Why it’s a deeper problem than you think

Hospice care is where families turn at the most vulnerable moments, when time is short and trust matters most. But if federal officials can shut down or flag more than 200 hospice providers in just a few weeks, something must be off.

When that many providers are suddenly swept up in fraud investigations, it raises a harder question: how long were these problems building before anyone stepped in?

Advertisement

That's the uncomfortable backdrop behind a wave of enforcement activity in Los Angeles, where authorities including Dr. Mehmet Oz – now the head of the Centers for Medicare and Medicaid Services – say fraudulent hospice schemes have siphoned tens of millions of dollars from Medicare.

Eight L.A.-area people were arrested in early April after authorities say they schemed to defraud the health care system of more than $50 million by billing Medicare for patients that weren't terminally ill or qualified for hospice care.

"The defendants charged today allegedly turned hospice care into a cash producing operation, resulting in more than $50 million in losses to taxpayers," Inspector General T. March Bell of the U.S. Department of Health and Human Services said in a news release announcing the arrests (1). "The magnitude of the losses underscores a deliberate abuse of the authority and trust afforded to health care providers."

And while the headlines focus on arrests and political finger-pointing, the real story sits closer to home: a system that's surprisingly easy to exploit and difficult for families to navigate.

What actually happened in LA

At the center of the crackdown is hospice care, a Medicare benefit designed for patients nearing the end of life. It's supposed to provide comfort when someone is terminally ill. Instead, prosecutors say some operators turned it into a business model.

In several cases, hospice providers allegedly enrolled patients who weren't terminally ill at all. Some were even offered cash incentives – hundreds of dollars a month – to sign up. Once enrolled, providers allegedly billed Medicare for unnecessary services, sometimes supplying basic items like vitamins or equipment to justify the claims. One case alone allegedly involved more than $9 million in billing.

Advertisement

Federal officials say multiple schemes like this were operating across the Los Angeles area. The Centers for Medicare and Medicaid Services, now led by Oz, has taken an aggressive stance, with Oz saying authorities "took out" 221 hospice providers from the system in recent weeks (2).

Nationally, suspected hospice fraud cost the health care system $198.1 million in 2023, according to HHS (3). In addition to the LA cases, other states – including Arizona, Nevada, Texas, Ohio and Georgia – have reported similar fraud (4).

Must Read

Join 250,000+ readers and get Moneywise’s best stories and exclusive interviews first — clear insights curated and delivered weekly. Subscribe now.

Why hospice is especially vulnerable

Hospice care sits in a strange corner of the health care system, one that blends medicine, emotion and timing.

That combination creates opportunity. Unlike many medical services, hospice eligibility depends on a doctor's judgment that a patient likely has six months or less to live. There's no single test that confirms it. That makes oversight tricky and opens the door for abuse.

Add in the financial structure, and the incentives become clearer.

Medicare often pays hospice providers a daily rate per patient. The longer someone stays enrolled, the more revenue a provider collects. If a patient isn't actually terminally ill, that stream can stretch far longer than intended.

What this means beyond California

Federal officials have already signaled that similar reviews could expand, and California itself has spent years trying to rein in a surge of hospice providers, revoking hundreds of licenses and pausing new ones. The California crackdown is a reminder that even well-intentioned systems can be gamed, and that oversight often lags behind innovation.

Advertisement

Here are some ways to avoid a hospice fraud trap:

Slow down: Pressure is a red flag. Hospice is meant for patients with a life expectancy of about six months or less, and the decision should involve a doctor you trust. If someone is pushing you to enroll quickly, offering perks or making it sound like an easy default, pause.

Verify: Look up the provider through Medicare's official comparison tools or your state health department. Check for licensing, complaints, and how long they've been in operation. A brand-new provider with little track record deserves extra scrutiny.

Watch for mismatches: Hospice care focuses on comfort, not cure. If a provider is offering unnecessary equipment, supplements or services that don't align with a patient's condition, that's a warning sign.

Article Sources

We rely only on vetted sources and credible third-party reporting. For details, see our ethics and guidelines.

U.S. Department of Justice (1)(2) ; Washington Examiner (3) ; KFF Health News (4)

You May Also Like

Share this:
Chris Clark Contributor

Chris Clark is a Kansas City–based freelance contributor for Moneywise, where he writes about the real financial choices facing everyday Americans—from saving for retirement to navigating housing and debt.

more from Chris Clark

Explore the latest

Disclaimer

The content provided on Moneywise is information to help users become financially literate. It is neither investment, tax nor legal advice, is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities, enter into any loan, mortgage or insurance agreements or to adopt any investment strategy. Tax, investment and all other decisions should be made, as appropriate, only with guidance from a qualified professional. We make no representation or warranty of any kind, either express or implied, with respect to the data provided, the timeliness thereof, the results to be obtained by the use thereof or any other matter. Advertisers are not responsible for the content of this site, including any editorials or reviews that may appear on this site. For complete and current information on any advertiser product, please visit their website.

†Terms and Conditions apply.